Detalhe da pesquisa
1.
An atlas of epithelial cell states and plasticity in lung adenocarcinoma.
Nature
; 627(8004): 656-663, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418883
2.
Immunotherapy response-associated Akkermansia: canary in a coal mine?
Trends Immunol
; 43(5): 337-339, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35397955
3.
Author Correction: An atlas of epithelial cell states and plasticity in lung adenocarcinoma.
Nature
; 628(8006): E1, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38499683
4.
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial.
Lancet
; 402(10405): 871-881, 2023 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37478883
5.
Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy.
Mod Pathol
; 37(1): 100353, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37844869
6.
Inhibition of nonsense-mediated decay rescues p53ß/γ isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancers.
J Biol Chem
; 297(5): 101163, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34481841
7.
Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge-December 1st-2nd, 2021.
J Transl Med
; 20(1): 271, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35706041
8.
Augmented Lipocalin-2 Is Associated with Chronic Obstructive Pulmonary Disease and Counteracts Lung Adenocarcinoma Development.
Am J Respir Crit Care Med
; 203(1): 90-101, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730093
9.
CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma.
Cancer Immunol Immunother
; 70(7): 1965-1976, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33416944
10.
18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer.
Cancer Immunol Immunother
; 69(8): 1519-1534, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32300858
11.
Applying Artificial Intelligence to Address the Knowledge Gaps in Cancer Care.
Oncologist
; 24(6): 772-782, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30446581
12.
Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancer.
Mod Pathol
; 31(6): 947-955, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29410488
13.
Will radiotherapy be a future part of neoadjuvant therapy in operable non-small-cell lung cancer?
Lancet Oncol
; 22(6): 744-746, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34015310
14.
Correction to: CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma.
Cancer Immunol Immunother
; 70(7): 1977-1978, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686493
15.
Neoadjuvant Chemoimmunotherapy for NSCLC: A Systematic Review and Meta-Analysis.
JAMA Oncol
; 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38512301
16.
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC.
J Thorac Oncol
; 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461929
17.
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors.
J Immunother Cancer
; 12(3)2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38458639
18.
Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancer.
J Thorac Cardiovasc Surg
; 167(4): 1444-1453.e4, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37816395
19.
Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC.
J Thorac Oncol
; 19(3): 500-506, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012986
20.
Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma.
Radiother Oncol
; 193: 110121, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38311031